Pine Valley Investments Ltd Liability Co Decreases Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Pine Valley Investments Ltd Liability Co decreased its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 14.8% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 8,845 shares of the exchange traded fund’s stock after selling 1,542 shares during the quarter. Pine Valley Investments Ltd Liability Co’s holdings in SPDR S&P Biotech ETF were worth $797,000 at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of XBI. Golden State Wealth Management LLC purchased a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter valued at about $29,000. Avior Wealth Management LLC increased its position in shares of SPDR S&P Biotech ETF by 393.6% during the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after purchasing an additional 307 shares during the last quarter. Tidemark LLC increased its position in shares of SPDR S&P Biotech ETF by 101.5% during the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after purchasing an additional 199 shares during the last quarter. Quintet Private Bank Europe S.A. purchased a new stake in shares of SPDR S&P Biotech ETF during the 3rd quarter valued at about $40,000. Finally, Bank of Jackson Hole Trust purchased a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter valued at about $43,000.

SPDR S&P Biotech ETF Stock Down 1.6 %

NYSEARCA XBI opened at $88.69 on Wednesday. SPDR S&P Biotech ETF has a 52 week low of $81.14 and a 52 week high of $105.47. The firm has a market capitalization of $6.76 billion, a P/E ratio of 11.47 and a beta of 1.11. The company has a 50-day moving average price of $91.14 and a 200-day moving average price of $95.92.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.